Quantys Clinical Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 16-07-2024
- Paid Up Capital ₹ 5.02 Cr
as on 16-07-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.50 Cr
as on 16-07-2024
- Revenue -44.84%
(FY 2023)
- Profit -56.38%
(FY 2023)
- Ebitda -166.63%
(FY 2023)
- Net Worth -59.60%
(FY 2023)
- Total Assets -14.00%
(FY 2023)
About Quantys Clinical
The Corporate was formerly known as Quest Care Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 5.02 Cr.
The company currently has active open charges totaling ₹12.50 Cr.
Navin Sexena and Kunal Saxena serve as directors at the Company.
- CIN/LLPIN
U74120MH2014PTC257021
- Company No.
257021
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Aug 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Quantys Clinical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navin Sexena  | Director | 08-Aug-2014 | Current |
| Kunal Saxena | Director | 08-Aug-2014 | Current |
Financial Performance of Quantys Clinical.
Quantys Clinical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.84% decrease. The company also saw a substantial fall in profitability, with a 56.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 59.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quantys Clinical?
In 2023, Quantys Clinical had a promoter holding of 59.77% and a public holding of 40.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Navin Saxena Research And Technology Private LimitedActive 30 years 1 monthNavin Sexena and Kunal Saxena are mutual person
Navicare Pharma Private LimitedActive 13 years 7 monthsNavin Sexena and Kunal Saxena are mutual person
Rusan Health Care Private LimitedActive 25 years 1 monthNavin Sexena and Kunal Saxena are mutual person
- Tuscany Holdings Private LimitedActive 30 years 2 months
Navin Sexena and Kunal Saxena are mutual person
Euromed International Private LimitedActive 26 years 11 monthsNavin Sexena and Kunal Saxena are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Small Industries Development Bank Of India Creation Date: 15 Sep 2015 | ₹12.50 Cr | Open |
How Many Employees Work at Quantys Clinical?
Quantys Clinical has a workforce of 31 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quantys Clinical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quantys Clinical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
